148 related articles for article (PubMed ID: 33247807)
1. A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?
Pluchart C; Barbe C; Poitevin G; Audonnet S; Nguyen P
J Thromb Thrombolysis; 2021 Apr; 51(3):711-719. PubMed ID: 33247807
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
[TBL] [Abstract][Full Text] [Related]
4. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.
Pluchart C; Poitevin G; Colinart-Thomas M; Guimard G; Audonnet S; Terryn C; Nguyen P
J Thromb Thrombolysis; 2019 Aug; 48(2):195-202. PubMed ID: 31175530
[TBL] [Abstract][Full Text] [Related]
5. Successful renal denervation decreases the platelet activation status in hypertensive patients.
Zaldivia MTK; Hering D; Marusic P; Sata Y; Lee R; Esler MD; Htun NM; Duval J; Hammond L; Flierl U; Wang X; Drummond GR; Walton A; Gardiner EE; Andrews RK; Schlaich MP; Peter K
Cardiovasc Res; 2020 Jan; 116(1):202-210. PubMed ID: 30715163
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE
Platelets; 2016 Dec; 27(8):805-811. PubMed ID: 27310292
[TBL] [Abstract][Full Text] [Related]
7. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
[TBL] [Abstract][Full Text] [Related]
8. Platelet Activation via Shear Stress Exposure Induces a Differing Pattern of Biomarkers of Activation versus Biochemical Agonists.
Roka-Moiia Y; Walk R; Palomares DE; Ammann KR; Dimasi A; Italiano JE; Sheriff J; Bluestein D; Slepian MJ
Thromb Haemost; 2020 May; 120(5):776-792. PubMed ID: 32369849
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.
Riedl J; Kaider A; Marosi C; Prager GW; Eichelberger B; Assinger A; Pabinger I; Panzer S; Ay C
Thromb Haemost; 2017 Jan; 117(1):90-98. PubMed ID: 27761580
[TBL] [Abstract][Full Text] [Related]
10. Procoagulant Effects of Low-Level Platelet Activation and Its Inhibition by Colchicine.
Reddel CJ; Pennings GJ; Curnow JL; Chen VM; Kritharides L
Thromb Haemost; 2018 Apr; 118(4):723-733. PubMed ID: 29554700
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia.
Chen J; Ngo D; Aldoss I; Shayani S; Tsai NC; Pullarkat V
Leuk Lymphoma; 2019 May; 60(5):1187-1192. PubMed ID: 30322332
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets.
Yu Y; Gool E; Berckmans RJ; Coumans FAW; Barendrecht AD; Maas C; van der Wel NN; Altevogt P; Sturk A; Nieuwland R
J Thromb Haemost; 2018 Jun; 16(6):1153-1163. PubMed ID: 29658195
[TBL] [Abstract][Full Text] [Related]
15. Platelet-enhanced plasma: Characterization of a novel candidate resuscitation fluid's extracellular vesicle content, clotting parameters, and thrombin generation capacity.
Price J; Gardiner C; Harrison P
Transfusion; 2021 Jul; 61(7):2179-2194. PubMed ID: 33948950
[TBL] [Abstract][Full Text] [Related]
16. Does anticoagulation prophylaxis reduce the rate of venous thromboembolism in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy?
Tong WH
Br J Haematol; 2022 Apr; 197(2):e24-e25. PubMed ID: 34713438
[No Abstract] [Full Text] [Related]
17. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
Goyal G; Bhatt VR
Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity.
Guerreiro EM; Kruglik SG; Swamy S; Latysheva N; Østerud B; Guigner JM; Sureau F; Bonneau S; Kuzmin AN; Prasad PN; Hansen JB; Hellesø OG; Snir O
J Thromb Haemost; 2024 May; 22(5):1463-1474. PubMed ID: 38266680
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
20. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
